March 28th 2025
The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in muscle invasive bladder cancer.
March 28th 2025
March 27th 2025
March 26th 2025
March 10th 2025
March 7th 2025
March 6th 2025
March 5th 2025
March 3rd 2025
February 23rd 2025
February 22nd 2025
February 1st 2025